$CNK

Bedard Caren sold (to issuer) $242K of CNK

Bedard Caren (SVP-Global Controller) sold (to issuer) 8,000 shares of Cinemark Holdings, Inc. (CNK) at $30.23 ($0.24M total) on 2026-06-04.

Original reporting
SEC EDGAR · Bedard Caren
Published Jun 8, 2026, 8:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNK
Neutral
medium confidence
Mentioned
$CNK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosure updates the record of an officer’s holdings after a sale to the issuer; it does not include guidance, litigation, or operational changes.

02

Market read

Traders may note the insider transaction for sentiment/flow monitoring, but there is no new fundamental catalyst in the text.

03

What to watch

The article doesn’t state whether the sale was part of a broader repurchase/employee liquidity mechanism beyond the 'sale to issuer' code; without that context, directional inference is weak.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-08 (covers sale dated 2026-06-04).

Background

The article is an SEC Form 4 insider transaction filing for Cinemark Holdings, Inc.

Company-level read

Ticker impact

$CNKNeutralMedium confidence
Context

Cinemark insider Bedard Caren (SVP-Global Controller) sold 8,000 shares to the issuer at $30.23 on 2026-06-04 via Form 4.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

Form 4 insider transactions are typically low-signal unless tied to unusual size, pattern, or accompanying corporate news; this filing provides transaction details but no new company catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

If the sale is tied to a company buyback program, it may reflect planned liquidity/administration rather than bearish insider conviction.

Key entities

  • Cinemark Holdings, Inc.

    CNK; subject of the Form 4 insider transaction disclosure.

  • Bedard Caren

    SVP-Global Controller who sold 8,000 shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMCMedAI 8/10

AMC vs. Cinemark: Which Theater Stock Is the Better Buy Now?

AMC and Cinemark reported record Q2 earnings, with AMC's revenue up 14.2% and Cinemark's surpassing $1B. Both benefit from strong box office trends but face challenges like high costs and debt. AMC's leverage is above target, while Cinemark's performance depends on movie releases and rising electricity costs. Analysts expect strong growth for both, with Cinemark showing slightly better financial strength and growth prospects.

$WBDLow

Warner Bros. Discovery Merger

Cinemark, a Texas-based theater operator, now supports the $110.8B Paramount-Warner Bros. Discovery merger, citing benefits for the box office and industry. AMC and Regal also back the deal, but California and the WGA oppose it, with a trial set for 2027.

$PARAMed

An Offer They Can’t Refuse: Theater Execs Split on Whether to Join Paramount-Warner’s Merger Movement

Paramount Skydance is seeking theater-industry support for its merger with Warner Bros. Discovery amid a legal fight with 12 state attorneys general. Regal and Vue CEOs backed the deal, citing David Ellison’s pledge to release 30 films a year. Paramount reportedly offered contracts for 30 films for at least three years, plus windowing terms and possible penalties.

$CNKMed

Cinemark Holdings, Inc. (CNK): Results of Operations and Financial Condition

Cinemark Holdings, Inc. (CNK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Generated all-time high quarterly revenue of $1.1 billion with records across all major revenue categories Delivered Net Income of $141 million, an increase of nearly 50% year-over-year Achieved our highest

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.